View in EDS

Targeting ACSS2 with a Transition-State Mimetic Inhibits Triple-Negative Breast Cancer Growth.

Saved in:
Bibliographic Details
Title: Targeting ACSS2 with a Transition-State Mimetic Inhibits Triple-Negative Breast Cancer Growth.
Authors: Miller KD; Molecular and Cellular Oncogenesis Program, Wistar Institute, Philadelphia, Pennsylvania., Pniewski K; Molecular and Cellular Oncogenesis Program, Wistar Institute, Philadelphia, Pennsylvania., Perry CE; Molecular and Cellular Oncogenesis Program, Wistar Institute, Philadelphia, Pennsylvania.; Cell & Molecular Biology Graduate Group, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Papp SB; Molecular and Cellular Oncogenesis Program, Wistar Institute, Philadelphia, Pennsylvania., Shaffer JD; Molecular and Cellular Oncogenesis Program, Wistar Institute, Philadelphia, Pennsylvania.; Cell & Molecular Biology Graduate Group, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Velasco-Silva JN; Molecular and Cellular Oncogenesis Program, Wistar Institute, Philadelphia, Pennsylvania.; Biochemistry Department, School of Medicine, University of Utah, Salt Lake City, Utah., Casciano JC; Molecular and Cellular Oncogenesis Program, Wistar Institute, Philadelphia, Pennsylvania., Aramburu TM; Gene Expression and Regulation Program, Wistar Institute, Philadelphia, Pennsylvania., Srikanth YVV; Molecular and Cellular Oncogenesis Program, Wistar Institute, Philadelphia, Pennsylvania., Cassel J; Molecular and Cellular Oncogenesis Program, Wistar Institute, Philadelphia, Pennsylvania., Skordalakes E; Gene Expression and Regulation Program, Wistar Institute, Philadelphia, Pennsylvania., Kossenkov AV; Molecular and Cellular Oncogenesis Program, Wistar Institute, Philadelphia, Pennsylvania., Salvino JM; Molecular and Cellular Oncogenesis Program, Wistar Institute, Philadelphia, Pennsylvania., Schug ZT; Molecular and Cellular Oncogenesis Program, Wistar Institute, Philadelphia, Pennsylvania. zschug@wistar.org.
Source: Cancer research [Cancer Res] 2021 Mar 01; Vol. 81 (5), pp. 1252-1264. Date of Electronic Publication: 2021 Jan 07.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-7445 (Electronic) Linking ISSN: 00085472 NLM ISO Abbreviation: Cancer Res Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1538-7445
DOI:10.1158/0008-5472.CAN-20-1847